Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

Enzyme Inhibitor ◽

Antihypertensive Efficacy ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Azilsartan Medoxomil

Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID ‐19?

Clinical Cardiology ◽

10.1002/clc.23473 ◽

2020 ◽

Author(s):

Xiao Liu ◽

Chuyan Long ◽

Qinmei Xiong ◽

Chen Chen ◽

Jianyong Ma ◽

...

Keyword(s):

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Use and COVID-19: Time to Change Practice or Keep Gathering Data?

Clinical Infectious Diseases ◽

10.1093/cid/ciaa819 ◽

2020 ◽

Vol 71 (9) ◽

pp. 2457-2458 ◽

Cited By ~ 1

Author(s):

Alejandro de Feria ◽

Juan M Ortega-Legaspi

Keyword(s):

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Gathering Data

COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy

Annals of Internal Medicine ◽

10.7326/m20-3047 ◽

2020 ◽

Vol 173 (3) ◽

pp. 237-238

Author(s):

William G. Kussmaul

Keyword(s):

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blocker Therapy ◽

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury

JAMA Internal Medicine ◽

10.1001/jamainternmed.2018.4749 ◽

2018 ◽

Vol 178 (12) ◽

pp. 1681 ◽

Cited By ~ 34

Author(s):

Sandeep Brar ◽

Feng Ye ◽

Matthew T. James ◽

Brenda Hemmelgarn ◽

Scott Klarenbach ◽

...

Keyword(s):

Acute Kidney Injury ◽

Enzyme Inhibitor ◽

Kidney Injury ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and Renal Outcomes—Reply

JAMA Internal Medicine ◽

10.1001/jamainternmed.2014.1578 ◽

2014 ◽

Vol 174 (10) ◽

pp. 1706

Author(s):

Chih-Cheng Hsu ◽

Jia-Sin Liu ◽

Der-Cherng Tarng

Keyword(s):

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Renal Outcomes

Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2013.10.050 ◽

2014 ◽

Vol 63 (7) ◽

pp. 650-658 ◽

Cited By ~ 83

Author(s):

Miklos Z. Molnar ◽

Kamyar Kalantar-Zadeh ◽

Evan H. Lott ◽

Jun Ling Lu ◽

Sandra M. Malakauskas ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

JAMA ◽

10.1001/jama.2020.11301 ◽

2020 ◽

Vol 324 (2) ◽

pp. 168 ◽

Cited By ~ 108

Author(s):

Emil L. Fosbøl ◽

Jawad H. Butt ◽

Lauge Østergaard ◽

Charlotte Andersson ◽

Christian Selmer ◽

...

Keyword(s):

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Comparison of Antihypertensive Effects of an Angiotensin-Converting Enzyme Inhibitor, a Calcium Antagonist and a Diuretic in Patients With Hypertension Not Controlled by Angiotensin Receptor Blocker Monotherapy

Yearbook of Cardiology ◽

10.1016/s0145-4145(07)70042-4 ◽

2006 ◽

Vol 2006 ◽

pp. 78-80

Author(s):

W.J. Elliott

Keyword(s):

Calcium Antagonist ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Faculty Opinions recommendation of Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718339270.793500454 ◽

2014 ◽

Author(s):

John Augoustides ◽

Sophia Cisler ◽

Elizabeth Valentine

Keyword(s):

Enzyme Inhibitor ◽

Elective Surgery ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Acute Dialysis

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry

Trials ◽

10.1186/s13063-015-1100-8 ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 2

Author(s):

Peter Bramlage ◽

◽

Roland E. Schmieder ◽

Anselm K. Gitt ◽

Peter Baumgart ◽

...

Keyword(s):

Clinical Trials ◽

Enzyme Inhibitor ◽

Routine Practice ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Azilsartan Medoxomil